Latest Developments in Middle East Africa Rice Based Infant Formula Market

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Latest Developments in Middle East Africa Rice Based Infant Formula Market

  • Food & Beverage
  • Oct 2021
  • MEA
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

  • In April 2024, Nestlé launched a new line of rice-based infant formulas under its NAN brand, designed specifically for infants with cow milk protein allergies and lactose intolerance. This product line emphasizes clean-label ingredients, non-GMO rice protein, and added micronutrients tailored for digestive sensitivity. The initiative underscores Nestlé’s continued focus on innovation in hypoallergenic and plant-based infant nutrition, particularly in emerging Asian markets with rising infant allergy concerns.
  • In March 2024, SCIENTIFIC BRAIN NUTRACEUTICAL PVT. LTD., an infant nutrition company, announced its expansion, introducing its rice-based infant formula products in Malaysia and Thailand. This move aligns with the company’s vision to offer affordable, easily digestible, and culturally relevant nutritional solutions in countries with high rice consumption and increasing awareness of alternative infant feeding options.
  • In February 2024, Danone partnered with regional pediatric associations to promote clinical research on rice-based infant formulas for infants with atopic dermatitis and food allergies. The collaboration aims to increase scientific validation and physician adoption of rice-based formulas as safe alternatives to cow milk-based options, particularly in sensitive populations. The partnership also supports Danone’s R&D leadership in growing medical nutrition sector.
  • In January 2024, Bellamy’s Organic introduced a certified organic rice-based follow-on formula for infants aged 6–12 months, targeting health-conscious parents. The product features organic brown rice protein, DHA from algae, and iron fortification, positioning it as a premium, natural alternative for infants with digestive sensitivities.
  • In December 2023, Abbott enhanced its Similac product line by launching a plant-based, rice-derived hypoallergenic infant formula through its e-commerce platforms. This marks Abbott’s first foray into rice protein-based formulas, reflecting growing consumer demand for vegan, lactose-free, and clean-label alternatives in infant nutrition.